Italy Country Drug Report 2019

Drug-related research

In Italy, research is coordinated by the Department for Anti-Drug Policies (DAP) and developed by a network of researchers and institutions such as the National Research Council, the National Statistical Office and the National Health Institute, as well as several ministries and local providers of public services, frequently in partnership with universities and/or private research entities. This set of entities provides studies that contribute to the annual report on drugs to the Italian parliament. Their main financing sources are the DAP, the National/Regional Health Services, the Ministry of Education, University and Research and the European Commission.

The Italian Action Plan recognises the importance of drug-related research, especially in the fields of neuroscience, neuroimaging, and behavioural, social and educational sciences. To this end, the DAP supports the development of an institutional scientific community. The outcomes of research are published both in national and international scientific journals.

Drug-related research covers a wide range of topics, including prevalence, patterns of substance use, risky behaviours, prevention and other interventions, new psychoactive substances, law enforcement and policy evaluation.

Italy main page

Methodological note: Analysis of trends is based only on those countries providing sufficient data to describe changes over the period specified. The reader should also be aware that monitoring patterns and trends in a hidden and stigmatised behaviour like drug use is both practically and methodologically challenging. For this reason, multiple sources of data are used for the purposes of analysis in this report. Caution is therefore required in interpretation, in particular when countries are compared on any single measure. Detailed information on methodology and caveats and comments on the limitations in the information set available can be found in the EMCDDA Statistical Bulletin.